Allergic Rhinitis Drugs Market Forecast 2014-2024: Future Prospects for Companies in Antihistamines, Corticosteroids, Immunotherapy & Vaccines
LONDON, June 15, 2015 /PRNewswire/ -- Report Details
Allergic rhinitis drugs – new study showing you trends, R&D progress, and predicted revenues
Where is the allergic rhinitis drugs market heading? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there.
Our 274-page report provides 204 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and national level. You will see financial results, interviews, trends, opportunities, and revenue predictions. Much opportunity remains in this growing pharma market.
Forecasts from 2014-2024 and other analyses show you commercial prospects
Besides revenue forecasting to 2024, our new study provides you with recent results, growth rates, and market shares. There you find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT and Porter's Five Forces Analysis), company profiles and commercial developments. Read the full transcripts of five exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales, including:
• Maureen Jenkins, Director of Clinical Services, Allergy UK
• Tonya Winders, President & CEO, Allergy and Asthma Network Mothers of Asthmatics (AANMA)
• Jonathan Bernstein, Professor, University of Cincinnati College of Medicine
• Hazel Econs, Financial & Marketing Director, Allergy Medical UK
• Kimihiro Okubo, Chairman and Professor, Nippon Medical School
Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, you will see forecasts to 2024 for these five submarkets:
• Oral antihistamines
• Intranasal corticosteroids
• Intranasal antihistamines
• Immunotherapy
• Other drugs.
Additionally, our new study provides global sales forecasts by volume for the intranasal corticosteroids and intranasal antihistamines submarkets, including individual global sales forecasts by volume for the leading drugs in these submarkets from 2014-2024.
Our investigation discusses what stimulates and restrains business. You find dynamics of the industry and assess its potential sales, seeing agents likely to achieve the most success.
See revenue forecasts for products
How will leading drugs perform to 2024 at the world level? Our study forecasts sales of 26 products, including these brands:
• Nasonex
• Allegra/Allegra-D/Allegra OTC
• Zyrtec/Zyrtec D
• Claritin/Claritin OTC
• Astepro
• Avamys/Veramyst
• Xyzal
• Allelock
• Staloral
• Clarinex
Discover how high revenues can go. You will see what is happening, understanding trends, challenges and opportunities.
Our analysis also breaks the main world forecast into geographical markets.
What are the prospects in the leading regions and countries?
In addition to analyses of the overall world market, you discover individual revenue forecasts for 12 national markets to 2024:
• US
• Japan
• China
• Germany
• France
• UK
• Italy
• Spain
• India
• Brazil
• Russia
• Mexico
• Rest of the World
There will be growth in established pharma markets and in developing countries. Our analyses show that India, China, Mexico and Brazil, in particular, will continue to achieve high revenue growth to 2024. Developments worldwide in product approval and pricing will influence the market.
Leading companies and potential for market growth
Overall world revenue for allergic rhinitis drugs will reach $11.3bn in 2014, our work forecasts. We predict revenue growth from 2014 to 2024. Rising demand for allergic rhinitis drugs, expanding healthcare coverage, econom
Download the full report: https://www.reportbuyer.com/product/2390351/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Share this article